Evidence map›Paper›PMID 40660046›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025

[Artificial intelligence under scrutiny: requirements, quality criteria, and testing tools for medical applications].

Jackie Ma, Eva Weicken, Frederik Pahde, Katharina Weitz, Sebastian Lapuschkin, Wojciech Samek, Thomas Wiegand

Abstract readEnglish AbstractReview
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jackie MaAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland. jackie.ma@hhi.fraunhofer.de.
Eva WeickenAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.
Frederik PahdeAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.
Katharina WeitzAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.
Sebastian LapuschkinAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.
Wojciech SamekAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.
Thomas WiegandAbteilung für Künstliche Intelligenz, Fraunhofer Heinrich-Hertz-Institut, HHI, Einsteinufer 37, 10587, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of artificial intelligence (AI) in medicine has great potential to improve quality and efficiency. At the same time, its use is associated with risks. In order to prevent harm, experts from research and politics are developing requirements, testing tools, and guidelines to identify and control these risks.This article first describes the requirements for AI in medicine. It then follows with a presentation of how concrete quality criteria and testing tools can be derived from those requirements. A deeper demonstration of "explainability" as a key criterion is presented as an example. A testing framework for the use of AI in medicine is also presented. Finally, the article provides an outlook on standardization of quality criteria.The development of AI, especially in medicine, is progressing quickly. Suitable testing procedures can help to minimize risks and strengthen trust in the technology. However, for the successful implementation of such testing procedures, continuous research efforts are necessary.

Indexed as

Artificial IntelligencePractice Guidelines as TopicQuality Assurance, Health CareGermanyHumansExplainabilityQuality criteriaStandardizationTesting criteriaTesting tools

Identifiers

PMID40660046
PMCPMC12287159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.